Brief Type: Advocacy Letter

On the Death of Chevron Deference, and the Strange Life of the USPSTF

Analysis of the ongoing regulatory and public health effects of the overturning of Chevron Deference and the Braidwood SCOTUS ruling.

Conditional Coverage: When Paperwork Replaces Policy in Medicaid

Comments on projected Medicaid coverage losses under the “One Big Beautiful Bill”

Medicare Part D/IRA PAWH Implications Comments

Comments to the HHS Office of Intergovernmental and External Affairs regarding implementation considerations for Medicare Part D and the Inflation Reduction Act (IRA) for people aging with HIV (PAWH).

Senate HELP Committee Leadership PBM Reform Comments

Comments to the leadership of the US Senate Health, Education, Labor, and Pensions (HELP) Committee regarding proposed reforms to the Pharmacy Benefit Manager (PBM) system.

Stakeholder Comment on Odefsey Affordability Review – HIV Access and Systems Considerations

Comments on the Oregon Prescription Drug Affordability Board’s affordability review of Odefsey.

Stakeholder Comment on Odefsey Affordability Review – HIV Access and Systems Considerations

Letter to Senate Leadership on the Pasteur Act

Co-signed letter to the leadership of the US Senate regarding the introduced Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act.

Oregon Health Authority Medicaid Waiver Comments

Comments on proposed formulary changes to Oregon’s Medicaid program to the Oregon Health Authority.

HHS Section 504 QALYs Comments

Comments on proposed revisions to the Older Americans Act in the context of Section 504 of the Rehabilitation Act and concerns regarding quality-adjusted life-years (QALYs).

Older Americans Act Comments

Comments on proposed revisions to the Older Americans Act regarding LGBTQI+ community and other considerations.